Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amiodarone pulmonary toxicity.

L Rakita, S M Sobol, N Mostow

    American Heart Journal
    |October 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Amiodarone therapy can cause serious lung damage, known as pulmonary toxicity. Reducing maintenance doses of amiodarone may help prevent this complication.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Evaluation of a proposed panel of cardiac markers for the diagnosis of acute myocardial infarction in patients with atraumatic chest pain.

    Archives of pathology & laboratory medicine·1998
    Same author

    Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy.

    Journal of the American College of Cardiology·1992
    Same author

    Hypoglossal-facial nerve interpositional-jump graft for facial reanimation without tongue atrophy.

    Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery·1991
    Same author

    Gadolinium-enhanced magnetic resonance imaging of the facial nerve in herpes zoster oticus and Bell's palsy: clinical implications.

    The American journal of otology·1991
    Same author

    Facial reanimation: the temporalis muscle and middle fossa surgery.

    The Laryngoscope·1991
    Same author

    Angiosarcoma of the maxillary sinus.

    Ear, nose, & throat journal·1990
    Same journal

    Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

    American heart journal·2026
    Same journal

    Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

    American heart journal·2026
    Same journal

    Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

    American heart journal·2026
    Same journal

    Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

    American heart journal·2026
    Same journal

    THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

    American heart journal·2026
    Same journal

    DOAC Score Among Patients Receiving Vitamin K Antagonists.

    American heart journal·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Pulmonology
    • Pharmacology

    Background:

    • Amiodarone is an effective antiarrhythmic drug.
    • Pulmonary toxicity is a serious side effect of amiodarone therapy.

    Observation:

    • This study evaluated 39 patients who developed pulmonary toxicity from amiodarone.
    • Most patients received maintenance doses over 400 mg/day.
    • Pulmonary function tests were not predictive of toxicity.

    Findings:

    • Patients improved after amiodarone withdrawal, with or without corticosteroids.
    • One patient's pulmonary changes resolved upon amiodarone withdrawal and did not recur upon reintroduction.
    • Reducing amiodarone maintenance dosage may decrease the frequency of pulmonary complications.

    Related Experiment Videos

    Implications:

    • Timely dose reduction of amiodarone is crucial for patient safety.
    • Further research is needed to understand the mechanism of amiodarone-induced pulmonary toxicity.
    • Clinicians should monitor patients for signs of pulmonary toxicity during amiodarone treatment.